Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy

BACKGROUND. In the U.S., neoadjuvant chemotherapy (NAC) for nonmetastatic breast cancer (BC) is used with extensive disease and aggressive molecular subtypes. Little is known about the influence of demographic characteristics, clinical factors, and resource constraints on NAC use in Africa. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Neil, Daniel S., Nietz, Sarah, Buccimazza, Ines, Singh, Urishka, Čačala, Sharon, Stopforth, Laura W., Joffe, Maureen, Jacobson, Judith S., Neugut, Alfred I., Crew, Katherine D., Ruff, Paul, Cubasch, Herbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Global Health and Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656461/
https://www.ncbi.nlm.nih.gov/pubmed/30518615
http://dx.doi.org/10.1634/theoncologist.2018-0535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656461/
https://www.ncbi.nlm.nih.gov/pubmed/30518615
http://dx.doi.org/10.1634/theoncologist.2018-0535

Ejemplares similares